Chemcrux Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2025 ,inter alia, to consider and approve 1. Unaudited Financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Chemcrux Enterprises has informed BSE that its Board of Directors will meet on 06 August 2025 to consider and approve the unaudited financial results for Q1 FY2025-26 (quarter ended 30 June 2025). The Board will also consider increasing the Authorised Share Capital of the company along with a consequent amendment to the Memorandum of Association, subject to shareholder approval. Additionally, the Board will deliberate on formulating and approving an Employee Stock Option Scheme (ESOP) under SEBI's Share Based Employee Benefits Regulations, 2021, also subject to shareholder approval. The Audit Committee will meet earlier on the same day, and the trading window for designated persons will reopen 48 hours after the results are announced.
This is a routine advance intimation. Investors should watch for the Q1 results on 06 August for actual performance signals. The proposed hike in Authorised Share Capital and a new ESOP scheme are forward-looking corporate actions that may dilute existing shareholders' stake depending on how they are eventually structured and approved.